Modern imaging technologies, such as high-resolution magnetic resonance imaging (MRI), micro-computed tomography (micro-CT), and advanced ultrasound provide researchers with clearer and more detailed images of biological structures. The integration of multimodal imaging systems is another advancement in preclinical imaging market as these systems combine multiple imaging techniques, such as PET-CT or PET-MRI, to provide complementary information and enhance the accuracy of preclinical studies which allows researchers to investigate multiple aspects of a disease or treatment simultaneously, leading to more comprehensive and reliable results.
Furthermore, there have been significant improvements in image analysis and data processing algorithms. Advanced software tools and machine learning algorithms enable researchers to extract quantitative data from images, automate image processing tasks, and improve the accuracy and efficiency of data analysis. These advancements save time and enhance the reproducibility and reliability of preclinical studies.
Access Full Report @ https://www.databridgemarketresearch.com/reports/north-america-preclinical-imaging-market
Data Bridge Market Research analyses that the North America Preclinical Imaging Market is expected to grow with a CAGR of 6.7% in the forecast period from 2023 to 2030, and is expected to reach USD 2,005,475.12 thousand by 2030 from USD 1,213,520.05 thousand in 2022.
Key Findings of the Study
Increasing Incidence of Chronic Diseases
Chronic diseases, such as cancer, cardiovascular diseases, and neurological disorders, are a significant burden on healthcare systems worldwide. Preclinical imaging plays a vital role in understanding the underlying mechanisms of these diseases and developing effective therapeutic interventions.
Preclinical imaging offers valuable insights into disease progression, treatment response, and the evaluation of potential drug candidates. It allows researchers to visualize and study biological processes in animal models, providing a better understanding of disease mechanisms and aiding in the development of targeted therapies. Preclinical imaging helps in streamline the drug development process and reduces the risk of failure in clinical trials by non-invasively monitoring disease progression and treatment efficacy.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Thousand
|
|
Segments Covered
|
Product (Systems and Services), Reagents (Preclinical Optical Imaging Reagents, Preclinical Nuclear Imaging Reagents, Preclinical MRI Contrast Agents, Preclinical Ultrasound Contrast Agents, and Preclinical CT Contrast Agents), Application (Research and Development, Drug Discovery, Bio-Distribution, Cancer Cell Detection, Bio-Markers, and Others), End User (Contract Research Organization, Pharmaceutical & Biotech Companies, Academic & Government Research Institutes, Diagnostics Center, and Others)
|
|
Countries Covered
|
U.S., Canada, and Mexico
|
|
Market Players Covered
|
PerkinElmer Inc. (U.S.), FUJIFILM Visualsonics, Inc (A Subsidiary of FUJIFILM Corporation) (Japan), Bruker (Germany), Hologic, Inc (U.S.), ZEISS Group (Germany), Agilent Technologies, Inc. (U.S.), Hamamatsu Photonics K.K. (Japan), Vieworks Co., Ltd (South Korea), LI-COR, Inc. (U.S.), Berthold Technologies GmbH & Co.KG (Germany), MILabs B.V (Natherlands) Trifoil Imaging (U.K.),, IVIM Technology Inc. (U.S.), MR Solutions (U.K.), AI4R (France), Photon etc (Canada) and among others
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis
The North America preclinical imaging market is segmented into four notable segments based on product, reagents, application, and end user.
- On the basis of product, the market is segmented into systems and services.
In 2023, the system segment is expected to dominate the North America preclinical imaging market
In 2023, the system segment is expected to dominate the market with the market share of 62.43% as it provides comprehensive, integrated, and efficient imaging solutions that facilitate multimodal imaging and enhance the research capabilities of scientists in preclinical studies.
- On the basis of reagents, the market is segmented into preclinical optical imaging reagents, preclinical nuclear imaging reagents, preclinical MRI contrast agents, preclinical ultrasound contrast agents, and preclinical CT contrast agents.
In 2023, the preclinical optical imaging reagents segment is expected to dominate the North America preclinical imaging market
In 2023, the preclinical optical imaging reagents segment is expected to dominate with the market share of 37.88% as it provides non-invasive, real-time, and targeted visualization of specific molecules and cellular processes in small animals.
- On the basis of application, the market is segmented into research and development, drug discovery, bio-distribution, cancer cell detection, Bio-Markers, and others. In 2023, research and development segment is expected to dominate the market with a market share of 33.15%
- On the basis of end user, the market is segmented into contract research organization, pharmaceutical & biotech companies, academic & government research institutes, diagnostics center, and others. In 2023, the contract research organization segment is expected to dominate the market with a share of 46.74%
Major Players
Data Bridge Market Research analyzes PerkinElmer Inc. (U.S.), FUJIFILM Visualsonics, Inc (A Subsidiary of FUJIFILM Corporation) (Japan), Bruker (Germany), Hologic, Inc (U.S.), Agilent Technologies, Inc. (U.S.) as the market players in this market.
Market Developments
- In November 2022, Bruker announced the acquisition of Inscopix, Inc., a neuroscience pioneer and market leader of miniaturized microscopes, known as miniscopes, for freely moving animal brain imaging. This helped the organization develop more revenue
- In April 2022, PerkinElmer, Inc. announced the expansion of its in vivo imaging portfolio with the launch of the Vega imaging system. This increased the company's product portfolio and overall revenue
- In May 2022, FUJIFILM Corporation announced the launch of Vevo F2, the world’s first ultra-high to low frequency (71MHz-1MHz) ultrasound and photoacoustic imaging system for preclinical use. The Vevo F2 features HD image processing technology and introduces a completely new signal pathway – from transducer to display screen. This enabled better image clarity, and when combined with multi-line processing, delivers significantly improved frame rates over earlier generation platforms
- In December 2021, Battery Ventures, a global, technology-focused investment firm, acquired LI-COR Biosciences, an industry-leading company that makes highly engineered instrumentation systems for environmental research, agriculture, drug discovery, protein research, and therapeutics development
- In October 2021, MR Solutions announced the launch of a new AI that revolutionizes Magnetic Resonance Imaging (MRI) for preclinical research. This helped the organization develop more revenue
Regional Analysis
Geographically, the countries covered in the market report are U.S., Canada, and Mexico.
As per Data Bridge Market Research analysis:
The U.S. is the fastest-growing and dominant region in the North America preclinical imaging market
The U.S. is expected to dominate and to fastest growing country in North America preclinical imaging market because of the higher level of investments by various manufacturers and increasing technological advancements in the region.
For more detailed information about the North America preclinical imaging market report, click here – https://www.databridgemarketresearch.com/reports/north-america-preclinical-imaging-market
